Tripalmitoyl-S-Glyceryl-Cysteine-Dependent OspA Vaccination of Toll-Like Receptor 2-Deficient Mice Results in Effective Protection fromBorrelia burgdorferiChallenge
Open Access
- 1 July 2003
- journal article
- Published by American Society for Microbiology in Infection and Immunity
- Vol. 71 (7) , 3894-3900
- https://doi.org/10.1128/iai.71.7.3894-3900.2003
Abstract
Toll-like receptor 2 (TLR2) is a transmembrane signal transducer for tripalmitoyl-S-glyceryl-cysteine (Pam3Cys)-modified lipoproteins, including OspA from the Lyme disease spirochete Borrelia burgdorferi. The Pam3Cys modification provides adjuvant activity for inducing humoral responses, suggesting that TLR2 could function as the adjuvant receptor for the OspA vaccine. The importance of TLR2 in the humoral response to OspA was confirmed, because overall levels of immunoglobulin G (IgG) were reduced in TLR2-deficient mice, when compared with those in wild-type mice. However, the levels of production of IgG1 were similar in both mouse strains, and the levels of induction of protective immunity were comparable. Unlipidated OspA was not immunogenic in wild-type or TLR2-deficient mice, indicating the lipid modification was active in the absence of TLR2. These findings indicate that the Pam3Cys modification of bacterial lipoprotein has adjuvant properties independent of TLR2 signaling.Keywords
This publication has 40 references indexed in Scilit:
- Cutting Edge: Role of Toll-Like Receptor 1 in Mediating Immune Response to Microbial LipoproteinsThe Journal of Immunology, 2002
- Hyporesponsiveness to vaccination with Borrelia burgdorferi OspA in humans and in TLR1- and TLR2-deficient miceNature Medicine, 2002
- Toll-Like Receptor 2 Is Required for Innate, But Not Acquired, Host Defense to Borrelia burgdorferiThe Journal of Immunology, 2002
- Toll-like receptors control activation of adaptive immune responsesNature Immunology, 2001
- Host Defense Mechanisms Triggered by Microbial Lipoproteins Through Toll-Like ReceptorsScience, 1999
- Borrelia burgdorferi OspA is an arthropod-specific transmission-blocking Lyme disease vaccine.The Journal of Experimental Medicine, 1996
- Induction of an outer surface protein on Borrelia burgdorferi during tick feeding.Proceedings of the National Academy of Sciences, 1995
- Lyme Borreliosis in Selected Strains and Ages of Laboratory MiceThe Journal of Infectious Diseases, 1990
- Specific Antibodies Elicited By Antigen Covalently Linked To A Synthetic AdjuvantImmunobiology, 1985
- Lyme Disease—a Tick-Borne Spirochetosis?Science, 1982